FDA has granted regular approval to Retevmo (selpercatinib) adult patients with locally advanced or metastatic solid tumors with a rearranged during transfection (RET) gene fusion that have progressed on or following prior systemic treatment or who have no satisfactory alternative treatment options.
FDA has approved Pedmark to reduce the risk of ototoxicity associated with cisplatin in pediatric patients 1 month and older with localized, non-metastatic solid tumors.
Foundation Medicine Inc., a pioneer in molecular profiling for cancer, and Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people with life-threatening diseases, has formed a collaboration to develop FoundationOne CDx as a companion diagnostic for Day One’s lead investigational therapy, DAY101 (tovorafenib).
Researchers from Memorial Sloan Kettering Cancer Center have discovered subclonal co-mutations and immunophenotypic profiles that can distinguish individual cells indicative of future AML relapse from others present after treatment using Mission Bio Inc.’s Tapestri Single-cell Multi-omics Measurable Residual Disease assay.
The 2024 Bypass Budget submitted by NCI Acting Director Douglas Lowy asks for $9.988 billion—$2.222 billion more than the 2023 document submitted by then director Ned Sharpless.
VCU Massey Cancer Center will serve as the National Program Office for the Alliance for Equity in Cancer Care, an initiative funded by the Merck Foundation and designed to make cancer care more equitable in the U.S. by helping cancer patients living in underserved communities receive timely access to high-quality, culturally responsive care.
Sunny R. K. Singh has joined the University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute as a hematologist/oncologist and director of the UAMS Baptist Health Cancer Center in North Little Rock.
Jonathan Laryea, chief of the Division of Colorectal Surgery in the Department of Surgery and medical director of cancer services at UAMS Winthrop P. Rockefeller Cancer Institute was named the Nolie and Norma Mumey Endowed Chair in Surgery in a Sept. 7 ceremony.
The University of Arkansas for Medical Sciences’ Fay W. Boozman College of Public Health will conduct trainings for faculty and students in health care programs offered at colleges or universities in Arkansas to address unconscious biases in health care. The trainings are supported by a $600,000 grant from the CDC.
NCI has awarded a five-year, $13.3 million grant to a collaborative study on sequential combinations of targeted inhibitors and immunotherapies against cancer.
